You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 2, February 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (25)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Prognosis/ Outcomes
 •Alert me on articles by topic

Measurement of Intraoperative Parathyroid Hormone Predicts Long-term Operative Success

Johan Westerdahl, MD, PhD; Pia Lindblom, MD; Anders Bergenfelz, PhD

Arch Surg. 2002;137:186-190.

Hypothesis  A decrease in the intraoperative parathyroid hormone (PTH) level predicts long-term operative success.

Design  A case series of consecutive patients undergoing parathyroidectomy with intraoperative PTH measurement.

Setting  A university hospital.

Patients and Intervention  One hundred two patients with sporadic primary hyperparathyroidism underwent parathyroidectomy according to the principles of unilateral exploration with intraoperative PTH measurement.

Main Outcome Measures  Longitudinal effects on levels of serum calcium and PTH.

Results  In 94 of 98 patients who underwent primary exploration because of a solitary adenoma, intraoperative PTH decreased at least 60% 15 minutes after gland excision. The 4 cases in which PTH fell to less than 60% were classified as false negatives. Patients examined for multiglandular disease (n = 4) were correctly predicted not to have an adenoma. Twenty-two patients (22%) were unavailable for 5-year follow-up. These patients were followed up for 2 months to 48 months (median, 24 months), and none developed recurrent primary hyperparathyroidism. Of the remaining 80 patients (78%), all but 1 patient had normal or slightly decreased serum calcium levels (mean ± SD, 9.24 ± 0.4 mg/dL [2.31 ± 0.10 mmol/L]) at 5-year follow-up. One patient with hypercalcemia (10.6 mg/dL [2.65 mmol/L]) was interpreted to have developed renal failure with secondary hyperparathyroidism. Thirty-four patients had elevated serum PTH levels at least once during the postoperative study period, with normal or slightly decreased calcium concentrations. The prediction of late postoperative normocalcemia by means of intraoperative PTH measurement had an overall accuracy of 95%.

Conclusions  The measurement of intraoperative PTH during surgery for primary hyperparathyroidism accurately differentiates between single- and multiple-gland disease and ensures good long-term results.


From the Department of Surgery, Lund University Hospital, Lund, Sweden.


RELATED ARTICLE

This Month in Archives of Surgery
Arch Surg. 2002;137(2):132.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Parathyroid Surgical Failures With Sufficient Decline of Intraoperative Parathyroid Hormone Levels: Unobserved Multiple Endocrine Neoplasia as an Explanation
Westerdahl and Bergenfelz
Arch Surg 2006;141:589-594.
ABSTRACT | FULL TEXT  

Rapid Intraoperative Immunoassay of Parathyroid Hormone and Other Hormones: A New Paradigm for Point-of-Care Testing
Sokoll et al.
Clin. Chem. 2004;50:1126-1135.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.